Ali S - Search Results

1

Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.

Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH. Banerjee S, et al. Among authors: ali s. Cancer Res. 2005 Oct 1;65(19):9064-72. doi: 10.1158/0008-5472.CAN-05-1330. Cancer Res. 2005. PMID: 16204081

2

Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1.

Ali S, Aranha O, Li Y, Pettit GR, Sarkar FH, Philip PA. Ali S, et al. Cancer Chemother Pharmacol. 2003 Sep;52(3):235-46. doi: 10.1007/s00280-003-0628-6. Epub 2003 Jun 14. Cancer Chemother Pharmacol. 2003. PMID: 12811511

3

Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line.

Li Y, Ellis KL, Ali S, El-Rayes BF, Nedeljkovic-Kurepa A, Kucuk O, Philip PA, Sarkar FH. Li Y, et al. Among authors: ali s. Pancreas. 2004 May;28(4):e90-5. doi: 10.1097/00006676-200405000-00020. Pancreas. 2004. PMID: 15097869

4

Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.

El-Rayes BF, Ali S, Sarkar FH, Philip PA. El-Rayes BF, et al. Among authors: ali s. Mol Cancer Ther. 2004 Nov;3(11):1421-6. Mol Cancer Ther. 2004. PMID: 15542781

5

Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.

Ali S, El-Rayes BF, Aranha O, Sarkar FH, Philip PA. Ali S, et al. Breast Cancer Res Treat. 2005 Mar;90(1):25-31. doi: 10.1007/s10549-004-2179-x. Breast Cancer Res Treat. 2005. PMID: 15770523

6

Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.

Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Li Y, et al. Among authors: ali s. Cancer Res. 2005 Aug 1;65(15):6934-42. doi: 10.1158/0008-5472.CAN-04-4604. Cancer Res. 2005. PMID: 16061678

7

Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.

Ali S, El-Rayes BF, Sarkar FH, Philip PA. Ali S, et al. Mol Cancer Ther. 2005 Dec;4(12):1943-51. doi: 10.1158/1535-7163.MCT-05-0065. Mol Cancer Ther. 2005. PMID: 16373709

8

Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.

Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Bhuiyan MM, et al. Among authors: ali s. Cancer Res. 2006 Oct 15;66(20):10064-72. doi: 10.1158/0008-5472.CAN-06-2011. Cancer Res. 2006. Retraction in: Cancer Res. 2018 Sep 15;78(18):5473. doi: 10.1158/0008-5472.CAN-18-1167 PMID: 17047070 Retracted.

9

Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH. El-Rayes BF, et al. Among authors: ali if, ali s. Cancer Res. 2006 Nov 1;66(21):10553-9. doi: 10.1158/0008-5472.CAN-06-2333. Cancer Res. 2006. Retraction in: Cancer Res. 2018 Sep 15;78(18):5472. doi: 10.1158/0008-5472.CAN-18-1168 PMID: 17079479 Retracted.

10

A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway.

Ahmed F, Adsule S, Ali AS, Banerjee S, Ali S, Kulkarni S, Padhye S, Sarkar FH. Ahmed F, et al. Among authors: ali s, ali as. Int J Cancer. 2007 Feb 15;120(4):734-42. doi: 10.1002/ijc.22383. Int J Cancer. 2007. PMID: 17131340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,236 results

Search Page

Filters